ATH
Click for more information
0.00% 0.5¢ alterity therapeutics limited

Research AD biomarkers to routine diagnostics, page-5

  1. m123456
    1,639 Posts.
    lightbulb Created with Sketch. 143
    clock Created with Sketch.
    15/03/21
    11:26
    Post #: 51768287
    ?? Pbt2 is worth way more than 3c or 4c a share. Why would alteriry sell it? I bet it they did it would be straight back into trials for AD and the dog concerns would disappear
    Last edited by m123456: 15/03/21
    ATH Price at posting: 3.5¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch. 3  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

TVN CSIRO backs Tivan's downstream tech for WA vanadium concentrate
right-arrow Created with Sketch.
ARU More, more, more: Arafura eyes another US$300M in funding for flagship
right-arrow Created with Sketch.
PLY PlaySide to take gamers back to Westeros with new PC title
right-arrow Created with Sketch.
YRL Yandal lines up prime gold targets at Ironstone Well-Barwidgee
right-arrow Created with Sketch.
SLS Historical prospects impress Solstice, with 25% copper and significant anomaly
right-arrow Created with Sketch.
NMT Neometals eyeing 80% stake in US-based precious metal waste recovery plant
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $26.22M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
4 1416666 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 1799365 2
View Market Depth
Last trade - 09.53am 28/05/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.